chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (No second dose) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (No second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (No second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment medication provided. The patient had to leave the country and had missed the second dose.
shingles/few days; This case was reported by a consumer via call center representative and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the Shingrix shot and within a few days developed a few shingles spots and inquired was that normal. The patient stated that, he/she had another shingles and had not any shingles at all for 2 years until he/she received the shot. The patient inquired why did he/she show signs without any prior outbreak to the shot. The patient asked about receiving Shingrix while experiencing an outbreak of shingles.
Had loss of hearing I still have loss of hearing; I was little upset right now because this morning I still haven't have my hearing and I am not really happy I am, it's very upsetting; This is a spontaneous report from a non-contactable consumer(patient) or other non hcp.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on an unspecified date in 2021, as single dose for covid-19 immunization. Medical history included ongoing hearing loss. concomitant medications were not reported. On an unspecified date in 2021, an hour after patient got shot, patient had loss of hearing and still have loss of hearing this morning. The patient stated that already have hearing loss and then when I got the shot all of a sudden I have, I can't hear. The patient further stated that patient was little upset right now because this morning still haven't have hearing and was not really happy and it's very upsetting. It was stated that the patient would call somebody Monday morning and see what they going to do about this. If this was correct, then patient don't know whether they get the second shot. The clinical outcome of event was unknown.  No follow-up attempts were possible; information about lot/batch number could not be obtained. No further information was expected.
About 1 wk after 1st Hep-B, developed swelling of hands & feet, and had joint aches. Seen Dr on 12/17, given anti-inflamatory. On 12/28, had fever, chills & rash, hospitalized. Pt dx with inflammatory arthritis.
Hives developed all over about 10 pm, while at work.  Vaccine administered at 11:00am same day.  Lips swollen and difficulty breathing.  Pt went to clinic ER for tx.
Scheduled for second COVID 19 dose. Pfizer Lot # EW0153 vial was reconstituted with .8 mL 0.9% sodium chloride instead of 1.8 mL. RN withdrew 0.3 mL diluent and administered IM to left deltoid. Pt remained for 15 minutes post injection. Patient reported arm pain at injection site and general tired feeling.  Symptoms were resolved within 24 hours.  No hospitalization required.
PART OF THE VACCINE WENT OUT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced part of the vaccine went out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of part of the vaccine went out was not reported. This report was non-serious.
Pt stated she had blurry vision in her right eye shortly after the vaccine. She was visibly shaken and had elevated blood pressure for her (140/85, 154/95 after first and second readings). Pt came in off wait list and was excited to receive vaccine, stated did not have any known medical conditions, after waiting her 15 minutes she came to the counter and said her right eye was blurry. We gave her cold water, placed her in the clinical services room with dimmed lights for 15-20 minutes. Her sight wasn't returning, she did not want us to call any additional help. We walked her to her car and will follow up with her at 9:30am 04/11/2021.
Onset of headache 56 hours after first dose, on Sunday May 30, 2021 at 7 pm.  Headache did not completely resolve until 11 days later after June 9, 2021.  I took OTC ibuprofen, slept more than usual, took pseudoephedrine , extra caffeine and remained fed and hydrated.  Nothing helped ease the pain and discomfort. I had two chiropractic adjustments which relieved the headache right away, but within 2 hours the pain had started to return.  This headache felt like a vice grip around my head, buzzing and full ears, difficulty focusing eyes and then related eye pain, tightness in neck and jaw. This is not a usual circumstance for me.  The same headache pain has started to return today, June 14, 2021.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave 11 patients Moderna Covid-19 Vaccine doses (lot # 046C21A) on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave 11 patients Moderna Covid-19 Vaccine doses (lot # 046C21A) on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021). On 06-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Gave 11 patients Moderna Covid-19 Vaccine doses (lot # 046C21A) on 6Oct2021 from a vial that had been moved from frozen to refrigerated storage when they received them on 30Aug2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided.  No treatment medication was provided.  Medical Assistant was reporting that they gave 11 patients Moderna Covid-19 Vaccine doses  on 6-Oct-2021 from a vial (lot: 046C21A) that had been moved from frozen to refrigerated storage when they received them on 30-Aug-2021.  It was the 2nd dose for this patient.
Arm pain lasted for about 2 months. Red/blue color around injection site which subsided with time. Visited rheumatologist and will receive physical therapy.
Mildly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mildly sore arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE PAIN (Mildly sore arm). At the time of the report, VACCINATION SITE PAIN (Mildly sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-335979, MOD-2021-335982 (Patient Link).
urticaria/angioedema day p/initial typhoid innocculation; recurred p/booster dose;
Hypersensitivity reaction, right upper extremity became inflamed after receiving immunization. Reaction resolved by 10/17/06. Evaluated on 10/16/06.
Pt. returned to vaccination site on 10/8/07 c/o Right ear swelling which began 10/6 and now also pain and drainage (Rt) ear. 3+ (Rt) tonsilar node. T99.2 p 68-Referred to Urgent Care Center since pt new to area and no PCP. Urgent Care Center 10/8 dxed Otitis Media with Adenopathy and Rxed with Augmentin. Returned to medical center ER on 10/9 c/o (Rt) facial pain,k, weakness, numbness, nausea, vomiting, vertigo, photophobia. CT scan no abnormalities. MRI confirmed exam for Ramsey Hunt Syndrome. She was high dose steroids, IV Acyclovir and Valium. Discharged 10/12/07. As 5/11/07 continued improvement. 11/20/07-record received for DOS 11/10-10/12/07-DC DX:Ramsay Hunt syndrome. Vesicles in right ear.C/O nausea, vomiting vertiginous feeling. Right cervical lymphadenopathy, painful with ear swelling right facial pain and subsequent numbness and weakness of upper and lower portions of face. Decreased sensation to both sides of face. Per 60 day follow up: When last spoke with her she was well on road to recovery, lost to followup.
No Adverse event.  Incorrect Vaccine given. Patient was to receive Men B Vaccine.
pt received Moderna Vaccine at 1017 on 20 JAN2021.  Pt has history of asthma, tachycordia, and eosmophillia.  pt experienced light headedness as well as dizziness at 1021.  BP 140/84 SPO2 99% HR 100 pt had been on pregnazone and came off the medication as recommended by her physician Clinical provider advised pt that she may have possible vasovagal due to vaccine reaction, however pt declined EMS transport services. pt took two doses from her inhaler and emergency department was notified and pt agreed to be transported to emergency department, and left clinic at 1038.
Redness, swelling, hive like bumps that grew into welts around site warm to touch.  Developed canker sores and joint pain and swelling.
pt saw PCP and was diagnosed positive for COVID; to ED with increasing SOB; requires 2 1/2L O2 via NC @ home chronically, at ED required 4L to maintain O2 sats; admitted to hosp; treated with antibiotics, dexamethasone, remdesivir, vitamin supplementation; DNR; pt's condition worsened during her hospitalization where she passed away
Kinrix given to a 2-yerar-old; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa-IPV (Kinrix) for prophylaxis.   On 28-MAR-2023, the patient received Kinrix. On 28-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix given to a 2-yerar-old). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 28-Mar-2023  The reporter was the patient. The medical assistant called to inquire what to look for with this patient. The medical assistant reported they inadvertently administered a Kinrix (prefilled) dose to a 2-year-old patient on the day of reporting.  The healthcare professional mentioned administered in their facility a few minutes ago. The reporter did not consent to follow up. The 2 year old patient inadvertently received Kinrix (prefilled) dose which led to inappropriate age at vaccine administration.
Client presented to Health Department with guardian. Reviewed 2 record for client, 1 electronic and 1 paper copy. Reviewed the date incorrectly for next V2V dose, and administered VZV dose too early. 2nd dose due 11/1/2019. Monitored client for approximately 20 minutes in clinic without any adverse reaction noted. Discussed with guardian that dose was given too early. Guardian was understanding about the incident. Called guardian to check on client; left voicemail to please return call.
Mother describes pet mal seizure after 6 month baby shots. Mother is RN and describes blank stare for 5-10 seconds.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with unspecified number of improperly stored ROTATEQ, (dose and route not provided) (lot number # L000569, expiration date: 13-JUL-2016; lot number # reported as L004456, expiration date: 07-AUG-2016; lot number # K022995, expiration date: 22-JUL-2016; lot number # K022992, expiration date: 30-JUN-2016; lot number # L008053, expiration date: 30-NOV-2016). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
No additional AE details available; vaccines were administered after experiencing temperature excursion; This spontaneous report as received from a medical assistant refers to a 12-month-old patient of unknown gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 20-OCT-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot number: T032932, expiration date: 28-SEP-2022; dose and route of administration not provided) (product storage error). The vaccine was stored in temperatures 6 degrees Fahrenheit to 14 degrees Fahrenheit (8.5 degrees Fahrenheit) for 0 hours 18 minutes and 0 seconds; 6 degrees Fahrenheit to 14 degrees Fahrenheit (11.9 degrees Fahrenheit) for 1 hour 0 minutes and 0 seconds. There was no previous temperature excursion. No adverse event was reported.
This spontaneous report was received from a female consumer reporting on herself. The patient's relevant medical history, past drug history, and concomitant medications were unknown. On 24-MAR-2016, while breast feeding, the patient received one dose of GARDASIL 9 (lot number, and expiration date were unknown) in her right arm (dose number, frequency and indication were not provided). It was unknown if this was her first injection. Concomitant medication was not reported. On the same day, the consumer noticed a very mild rash and oral mucosal eruption on her 6-month old daughter's mouth and neck. (Captured in MARRS#1603USA03007). This is one of two reports from the same source. Additional information has been requested.
Painful, swollen, red arm. Fever of 103.5, nausea, vomiting.
3FEB94 hand stiffness & soreness & numbness of fingers; 18FEB94 feet & ankles sore & swollen; 9MAR93 some swelling & pain in knees; pain most severe during noc; 26APR94 finger swelling & stiffness;
Redness, swelling at injection site, itchy w/in few hrs of vaccine - worsening over next few days. Improved w/oral BENADRYL.
No adverse effect; HCP called to report a TE with PROQUAD.  Improperly stored.; This spontaneous report has been received from a medical assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 14-JUL-2023, the patient was vaccinated with improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection, at a dose of 0.5 milliliters as prophylaxis (lot number: W029555, which was determined to be valid, with an expiration date on 14-MAR-2024) (strengths, scheme, route and anatomical location of administration were not reported).  The administered dose underwent a temperature excursion of unreported temperature during an unspecified period time. Previous temperature excursion was not reported.    No additional adverse event was provided.  This is one of several reports from the same reporter.
This spontaneous case reported by a consumer, describes the occurrence of dizziness and diarrhea in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient had dizziness and diarrhea. At the time of the report, dizziness and diarrhea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Site: Pain at Injection Site-Medium, Additional Details: patient got the vaccine on 3/15/2023 and came to the pharmacy today on 5/5/23 and said his arm still hurts and and he cannot lift it over his head. pain limits pt's daily activity. pt is going to follow up with his MD
Metallic taste in mouth; This is a spontaneous report from a contactable consumer. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Apr2021 (age at vaccination unknown) as a single dose for COVID-19 immunisation. It was unknown if the patient had any other medical history and known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was not known if the patient received any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient experienced metallic taste in mouth. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event metallic taste in mouth was resolved on 23Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This patien was give afluria which is only to be given to 18 and older.                          I-92579218 and I-92318744
Fever; Chills; Rapid heartbeat for a number of hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Lot number: EN6198) at the age of 60 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number:01, Lot number:EN5318, No events reported), administration date: 28Jan2021, when the patient was 59 years old, for Covid-19 Immunization. The following information was reported: PYREXIA (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "Fever"; CHILLS (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "Chills"; HEART RATE INCREASED (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "Rapid heartbeat for a number of hours". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: After the second covid vaccine he had fever, chills, rapid heartbeat for a number of hours. He was told it would go away and it did. It lasted 8-10 hours.   Follow-up attempts are completed. No further information is expected..
I have itching, burning, swelling, and fever. On the back of my leg, it was hot to the touch. I tried Neosporin and Cortisone 10 and nothing I tried made it go away. I went in to see my doctor until 08/24/2021. It got to the point where I was still running fever and not sleeping at night. It felt like knives stabbing into the back of my leg. My foot was swollen. My ankle was swollen. She said it was oozing a yellow watery looking thing. I was covered in blisters. She touched it with a cotton swab and sent it to the lab. It came back negative for any kind of plant reaction (poison ivy). I still have stuff on the bottom of my foot and the bottom of my leg on my right side. The spot on my shoulder is still kind of broke out, but it is getting better. It feels like a rash under the skin. I have felt bad and my blood pressure has been through the roof. I'm running 155-160 in my blood pressure. That's way high for me especially since I take blood pressure medication.
This spontaneous report was received from a back office lead and refers to a 48 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 23-MAR-2016, the patient was vaccinated with the improperly stored dose of RECOMBIVAX HB (1 ml, intramuscularly in unspecified deltoid, lot # reported as 042846, expiration 15-SEP-2017). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information is not expected as all the correspondence was returned by the post office.
lips were tingly / numb for about 30 minutes and then that feeling gradually dissipated and everything was fine after that.
received a group of vaccines and developed a full body rash; Redness; This is a spontaneous report from a contactable nurse and physician through a Pfizer sales representative.  A 4-month-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Lot. CW5294, Expiration date: Jun2022) at single dose; diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine Inact 3v (mrc 5), tetanus vaccine toxoid (PENTACEL) and rotavirus vaccine live reassort oral 5v (ROTATEQ); all on an unspecified date, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced rash/redness described as "baby received a group of vaccines and developed a full body rash". Clinical outcome of the adverse events was unknown at time of this report.   No follow-up attempts are needed. No further information is expected.
Swelling and soreness at injection site 8 hours after vaccine administered followed by moderate fever of 99.5, body aches and pains, excessive urination, and headache throughout the first night, and continuing in following day.